2014•Experimental and Laboratory MedicineRequires access

Clinical value of non-HDL-cholesterol in coronary heart disease diagnoses

Deng Rong-chu

Open publisher page 0 citations

Abstract

Objective To investigate the clinical value of non-high-density lipoprotein cholesterol(non-HDL-C) and apolipoprotein B(apoB) in patients with coronary heart disease(CHD). Methods The concentrations of serum triglyceride(TG),total cholesterol(TC), high-density lipoprotein cholesterol(HDL-C), low-density lipoprotein cholesterol(LDL-C), apolipoprotein A1(apoA1) and apoB in 118 patients with CHD were detected. Non-HDL-C levels and apoB/apoA1 ratios were calculated. All the results were analyzed with statistical methods. Results The concentrations of serum TG, non-HDL-C and the ratio of apoB/apoA1 in patients with CHD were significantly higher than those of healthy people(P0.01), while HDL-C and apoA1 were lower(P0.01).Serum HDL-C and apoA1 have higher diagnostic sensitivity in CHD than serum TC and LDL-C, while serum non-HDL-C, apoB and apoB/apoA1 had higher specificity. Conclusions Serum non-HDL-C and apoB/apoA1 have positive correlation with CHD and their early warning value are better than serum LDL-C and TC. In patients with normal serum LDL-C and TC, controlling their serum non-HDL-C and apoB will have more significance in prevention of CHD.

About this research paper

What this paper is about

Objective To investigate the clinical value of non-high-density lipoprotein cholesterol(non-HDL-C) and apolipoprotein B(apoB) in patients with coronary heart disease(CHD). Methods The concentrations of serum triglyceride(TG),total cholesterol(TC), high-density lipoprotein cholesterol(HDL-C), low-density lipoprotein cholesterol(LDL-C), apolipoprotein A1(apoA1) and apoB in 118 patients with CHD were detected. Non-HDL-C levels and apoB/apoA1 ratios were calculated. All the results were analyzed with statistical methods. Results The concentrations of serum TG, non-HDL-C and the ratio of apoB/apoA1 in patients with CHD were significantly higher than those of healthy people(P0.01), while HDL-C and apoA1 were lower(P0.01).Serum HDL-C and apoA1 have higher diagnostic sensitivity in CHD than serum TC and LDL-C, while serum non-HDL-C, apoB and apoB/apoA1 had higher specificity. Conclusions Serum non-HDL-C and apoB/apoA1 have positive correlation with CHD and their early warning value are better than serum LDL-C and TC. In patients with normal serum LDL-C and TC, controlling their serum non-HDL-C and apoB will have more significance in prevention of CHD.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the clinical value of non-high-density lipoprotein cholesterol(non-HDL-C) and apolipoprotein B(apoB) in patients with coronary heart disease(CHD). Methods The concentrations of serum triglyceride(TG),total cholesterol(TC), high-density lipoprotein cholesterol(HDL-C), low-density lipoprotein cholesterol(LDL-C), apolipoprotein A1(apoA1) and apoB in 118 patients with CHD were detected. Non-HDL-C levels and apoB/apoA1 ratios were calculated. All the results were analyzed with statistical methods. Results The concentrations of serum TG, non-HDL-C and the ratio of apoB/apoA1 in patients with CHD were significantly higher than those of healthy people(P0.01), while HDL-C and apoA1 were lower(P0.01).Serum HDL-C and apoA1 have higher diagnostic sensitivity in CHD than serum TC and LDL-C, while serum non-HDL-C, apoB and apoB/apoA1 had higher specificity. Conclusions Serum non-HDL-C and apoB/apoA1 have positive correlation with CHD and their early warning value are better than serum LDL-C and TC. In patients with normal serum LDL-C and TC, controlling their serum non-HDL-C and apoB will have more significance in prevention of CHD.

Key concepts: Apolipoprotein B, Internal medicine, Apolipoprotein A1, Medicine, Endocrinology, Triglyceride, Cholesterol, Coronary heart disease

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical value of non-HDL-cholesterol in coronary heart disease diagnoses — Research Paper | ScholarLens